Optimal control with multiple human papillomavirus vaccines

9 Jul 2018, 11:30
New Law School/--101 (University of Sydney)

New Law School/--101

University of Sydney

Oral Presentation Minisymposium: Advances in Mathematics of Infectious Diseases Advances in mathematics of infectious diseases


Tufail Malik (Merck & Co., Inc., USA)


Many human papillomavirus (HPV) vaccination programs currently administer three vaccines - a bivalent, a quadrivalent and a nonavalent vaccine - for a two-dose course. In this talk a model will be presented to explore optimal vaccination strategies using the three vaccines, which differ in protection breadth, cross-protection, and type-specific efficacy. Assuming the HPV infection prevalence in the population under the constant vaccination regime, optimal control theory will be used to discuss optimal vaccination strategies for the associated non-autonomous model when the vaccination rates are functions of time. The impact of these strategies on the number of infected individuals and the accumulated cost will be assessed and compared with the constant control case. Switch times from one vaccine combination to a different combination including the nonavalent vaccine will be assessed during an optimally designed HPV immunization program.

Primary authors

Tufail Malik (Merck & Co., Inc., USA) Mudassar Imran (Arizona State University) Raja Jayaraman (Arizona State University)

Presentation Materials

There are no materials yet.